Terpenes in the management of chronic kidney disease

被引:1
|
作者
Kulkarni, Piyusha [1 ]
Yeram, Pranali B. [1 ]
Vora, Amisha [1 ]
机构
[1] Shri Vile Parle Kelavani Mandals Narsee Monjee Ins, Shobhaben Pratapbhai Patel Sch Pharm & Technol Man, Mumbai 400056, India
关键词
Chronic kidney disease (CKD); Terpenes; Renal dysfunction; Acute Kidney Disease (AKI); GLYCATION END-PRODUCTS; DIABETES-MELLITUS; OXIDATIVE STRESS; ANTIINFLAMMATORY ACTIVITY; HYPERTENSION; INJURY; INFLAMMATION; COMPLICATIONS; HYPERGLYCEMIA; EPIDEMIOLOGY;
D O I
10.1007/s00210-024-03098-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic kidney disease (CKD) is a chronic and progressive systemic condition that characterizes irreversible alterations in the kidneys' function and structure over an extended period, spanning months to years. CKD is the one of the major causes of mortality worldwide. However, very limited treatment options are available in the market for management of the CKD. Diabetes and hypertension are the key risk factors for the progression of CKD. It is majorly characterised by glomerulosclerosis, tubular atrophy, and interstitial fibrosis. Plants are considered safe and effective in treating various chronic conditions. A diverse group of phytoconstituents, including polyphenols, flavonoids, alkaloids, tannins, saponins, and terpenes, have found significant benefits in managing chronic ailments. Terpenes constitute a diverse group of plant compounds with various therapeutic benefits. Evidence-based pharmacological studies underscore the crucial role played by terpenes in preventing and managing CKD. These substances demonstrate the capacity to hinder detrimental pathways, such as oxidative stress, inflammation and fibrosis, thereby demonstrating benefit in renal dysfunction. This review offers a comprehensive overview of the roles and positive attributes of commonly occurring terpenes in managing the causes and risk factors of CKD and the associated conditions.
引用
收藏
页码:6351 / 6368
页数:18
相关论文
共 50 条
  • [21] Frontiers in chronic kidney disease management
    Owoyemi, Itunu
    Balogun, Rasheed Abiodun
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2022, 114 (03) : S1 - S2
  • [22] Management of chronic kidney disease in the elderly
    Ng, B. L.
    Anpalahan, M.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (11) : 761 - 768
  • [23] Management of Hypertension in Chronic Kidney Disease
    Dan Pugh
    Peter J. Gallacher
    Neeraj Dhaun
    Drugs, 2019, 79 : 365 - 379
  • [24] Management of hyperkalaemia in chronic kidney disease
    Csaba P. Kovesdy
    Nature Reviews Nephrology, 2014, 10 : 653 - 662
  • [25] Management of hyperkalaemia in chronic kidney disease
    Kovesdy, Csaba P.
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (11) : 653 - 662
  • [26] Management of Osteoporosis in Chronic Kidney Disease
    Nitta, Kosaku
    Yajima, Aiji
    Tsuchiya, Ken
    INTERNAL MEDICINE, 2017, 56 (24) : 3271 - 3276
  • [27] Phosphate management in chronic kidney disease
    Bhan, Ishir
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (02): : 174 - 179
  • [28] Hypertension management in chronic kidney disease
    Mallamaci, Francesca
    Pisano, Anna
    Tripepi, Giovanni
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (12) : 2194 - 2195
  • [29] Management of the Chronic Kidney Disease Patient
    Link, Denise K.
    PHYSICIAN ASSISTANT CLINICS, 2016, 1 (01) : 43 - 54
  • [30] Advances in the management of chronic kidney disease
    Chen, Teresa K.
    Hoenig, Melanie P.
    Nitsch, Dorothea
    Grams, Morgan E.
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 383